Literature DB >> 1527553

Rectal apomorphine: a new treatment modality in Parkinson's disease.

T Van Laar, E N Jansen, A W Essink, W J Rutten, C Neef.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527553      PMCID: PMC489221          DOI: 10.1136/jnnp.55.8.737-a

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  ['New wine in old bottles'; therapy for Parkinson disease using subcutaneous apomorphine].

Authors:  E N Jansen; T van Laar
Journal:  Ned Tijdschr Geneeskd       Date:  1990-05-05

2.  Subcutaneous apomorphine in the treatment of Parkinson's disease.

Authors:  J P Frankel; A J Lees; P A Kempster; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

3.  Subcutaneous infusion of apomorphine and lisuride in the treatment of parkinsonian on-off fluctuations.

Authors:  C Stibe; A Lees; G Stern
Journal:  Lancet       Date:  1987-04-11       Impact factor: 79.321

  3 in total
  3 in total

Review 1.  Old Drugs, New Delivery Systems in Parkinson's Disease.

Authors:  Harsh V Gupta; Kelly E Lyons; Rajesh Pahwa
Journal:  Drugs Aging       Date:  2019-09       Impact factor: 3.923

2.  Apomorphine pharmacokinetics in parkinsonism after intranasal and subcutaneous application.

Authors:  E Sam; A P Jeanjean; J M Maloteaux; N Verbeke
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Jan-Mar       Impact factor: 2.441

Review 3.  Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease.

Authors:  Nrupa Borkar; Huiling Mu; René Holm
Journal:  Asian J Pharm Sci       Date:  2017-12-06       Impact factor: 6.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.